Evidence map›Paper›PMID 29342269›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2018

A Silent Epidemic: The Prevalence, Incidence and Persistence of Mycoplasma genitalium Among Young, Asymptomatic High-Risk Women in the United States.

Arlene C Seña, Jeannette Y Lee, Jane Schwebke, Susan S Philip, Harold C Wiesenfeld, Anne M Rompalo, Robert L Cook, Marcia M Hobbs

Open access · bronzeAbstract readMulticenter Study
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 62 citations in OpenAlex.

  1. Trial
  2. Article
  3. PreconceptionmedRxiv : the preprint server for health sciences · 2026
    Article
  4. Article
  5. Tropical medicine and infectious disease · 2025
    Article
  6. Prevalence ofOpen forum infectious diseases · 2024
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Management of Pelvic Inflammatory Disease in Clinical Practice.Therapeutics and clinical risk management · 2023
    Review
  12. Frontiers in microbiology · 2023
    Review
  13. The prevalence of Mycoplasma genitalium (MG) and Trichomonas vaginalis (TV) at testing centers in Belgium, Germany, Spain, and the UK using the cobas TV/MG molecular assay.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2023
    Article
  14. Article
  15. High Rates of AsymptomaticOpen forum infectious diseases · 2022
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 7 institutions in 1 country.

Arlene C SeñaDepartment of Medicine, Institute for Global Health and Infectious Diseases, University of North Carolina at Chapel Hill.
Jeannette Y LeeDepartment of Biostatistics, University of Arkansas for Medical Sciences, Little Rock.
Jane SchwebkeDepartment of Medicine, University of Alabama at Birmingham.
Susan S PhilipSan Francisco Department of Public Health, California.
Harold C WiesenfeldDepartment of Obstetrics and Gynecology, Magee-Women's Hospital of University of Pittsburgh Medical Center, Pennsylvania.
Anne M RompaloDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Robert L CookDepartments of Epidemiology and Medicine, University of Florida, Gainesville.
Marcia M HobbsDepartment of Medicine, Institute for Global Health and Infectious Diseases, University of North Carolina at Chapel Hill.
University of North Carolina at Chapel Hill · USJohns Hopkins University · USSan Francisco Department of Public Health · USUniversity of Alabama at Birmingham · USUniversity of Arkansas for Medical Sciences · USUniversity of Florida · USUniversity of Pittsburgh Medical Center · US

Funding

Virology, Immunology, and Microbiology CoreP30AI050410 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DAVID M. MARGOLIS · 2001 to 2026
$76.9M
Trichomonas Typing SystemU19AI031496 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SPARLING, PHILIP FREDERICK · 1995 to 2014
$24.9M
NIAID NIH HHS P30 AI050410NIAID NIH HHS U19 AI031496
6 · The paper itself

Abstract

Background: Mycoplasma genitalium can result in pelvic inflammatory disease and adverse pregnancy outcomes. We analyzed data collected from a prospective study of asymptomatic bacterial vaginosis (BV) to determine the natural history of M. genitalium. Methods: Women aged 15-25 years, with asymptomatic BV and ≥2 risk factors for sexually transmitted infection were recruited from 10 sites throughout the United States. Vaginal swab samples were collected at enrollment and through home-based testing every 2 months over 12 months. M. genitalium nucleic acid amplification testing was performed for M. genitalium using transcription-mediated assays (Hologic). The prevalence, incidence, and persistence of M. genitalium, defined as all positive specimens during follow-up, were estimated with 95% confidence intervals (CIs). Adjusted odds ratios (AOR) were calculated using logistic and Poisson regression to evaluate participant characteristics associated with M. genitalium infection. Results: Among 1139 women, 233 were M. genitalium positive, for a prevalence of 20.5% (95% CI, 18.2%-22.9%); 42 of 204 had persistent M. genitalium (20.6%). Among 801 M. genitalium-negative women at baseline, the M. genitalium incidence was 36.6 per 100 person-years (95% CI, 32.4-41.3). Black race (AOR, 1.92; 95% CI, 1.09-3.38), age ≤21 years (1.40; 1.03-1.91), and prior pregnancy (1.36; 1.00-1.85) were associated with prevalent M. genitalium; only black race was associated with incident M. genitalium (P = .03). Conclusions: We identified high rates of prevalent, incident, and persistent M. genitalium infections among young, high-risk women with asymptomatic BV, supporting the need for clinical trials to evaluate the impact of M. genitalium screening on female reproductive health outcomes.

Indexed as

AdolescentAdultAsymptomatic InfectionsCoinfectionFemaleHumansIncidenceMycoplasma genitaliumMycoplasma InfectionsOdds RatioPelvic Inflammatory DiseasePrevalenceProspective StudiesRegression AnalysisRisk FactorsSexual Behavior

Identifiers

PMID29342269
PMCPMC6005142
OpenAlexW2782871169

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.